Document is current
Any future updates will be listed below
-
Authors
Bhatia, Rakesh
Khan, Imran
Li, Xiaoqi
Gautam, Shailendra
Seshacharyulu, Parthasarathy
Alsafwani, Zahraa Wajih
Bhyravbhatla, Namita
Ponnusamy, Moorthy P.
Jain, Maneesh
Malafa, Mokenge
Bindu, Santhamma
Gulzar, Ahmed
Nair, Hareesh
Batra, Surinder K.
Kumar, Sushil
-
Funding
Funding for this research was provided by:
National Cancer Center,United States (RO1 CA210637, R01 CA247471)
National Cancer Center,United States, (R44 CA235991, R44 CA235991)
National Cancer Center (PO1 CA217798)
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 8 July 2025
First Online: 22 August 2025
Competing interests
: S.K.B. is one of the founders of Sanguine Diagnostics and Therapeutics, Inc. H.N., S.B. and A.G. are employees of Evestra and holders of a patent on EC359. The other authors declare no competing interests.
